Net income 1, 3 245, 2 220. Net margin, 21,3%, 15,2%. EPS 2, 10,9, 7,47. Dividend per Share 2, -, -. Last update, 02/18/2021, 03/30/2021. 1 SEK in Million.

The Swedish Orphan Biovitrum AB (publ) PE ratio based on its reported earnings over the past 12 months is 14.38.The shares are currently trading at SEK141.45.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors.

Price target in 14 days: 148.695 SEK. The best long-term & short-term Swedish In depth view into BIOVF (Swedish Orphan Biovitrum) stock including the latest price, news, dividend history, earnings information and financials. Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help you make more Sobi marknadsför även en portfölj specialist- och särläkemedel på uppdrag av olika partnerföretag. Intäkterna uppgick 2013 till 2,2 miljarder kronor och antalet 2 dagar sedan SBB ligger i topp över Stockholmsbörsens mest blankade bolag tätt följt av Scandic och Elekta. Det framgår av finansinspektionens 9 Feb 2021 But there's a flip side to this volatility, which can make biotechs harder to trade.

DJIA. 33,730.89. S&P 500. 4,124.66.

The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment 2021-04-15 · Swedish Orphan Biovitrum AB (BIOVF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2020-12-24 · Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceutical.

Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help you make more

Swedish Orphan Biovitrum utdelning och direktavkastning Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) announced today that it has commenced a tender offer through its indirect wholly owned subsidiary Dragonfly Acquisition Corp. (Dragonfly) to purchase all outstanding shares of Dova Pharmaceuticals, Inc. (Dova) (NASDAQ: DOVA), at a price of USD 27.50 per share in cash plus one non-tradeable Contingent Value Right (CVR). SWEDISH ORPHAN BIOVITRUM AB (PUBL) 0MTD Trade recap - Search stock, chart, recent trades, company information, trading information, company news, fundamentals This information is information that Swedish Orphan Biovitrum AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.

✖ Safari-användare: Om du upplever problem med Shareville, öppna webbläsarens Inställningar -> Integritet, och avbocka 'Förhindra spårning mellan

Created with Highstock 2.0.1 SOBI Volym 09:00 10:00 11:00 12:00 13:00 14:00 Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) 2021-02-18 08:00:00 Bokslutskommuniké, Sobi publishes report for the fourth Köp aktien Swedish Orphan Biovitrum AB (SOBI). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. Få detaljerad information om Swedish Orphan Biovitrum AB (SOBIV) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Swedish Orphan Biovitrum Investing.com användarnas resultattavla för Swedish Orphan Biovitrum AB aktien.

For Swedish Orphan Biovitrum Ab (publ), the figure is an eye-catching 15.3%. Swedish Orphan Biovitrum's Earnings Growth And 17% ROE . To begin with, Swedish Orphan Biovitrum seems to have a respectable ROE. Further, the company's ROE is similar to the industry average of 14%. Consequently, this likely laid the ground for the impressive net income growth of 44% seen over the past five years by Swedish Orphan Biovitrum.
Brio self cleaning bottleless water cooler

Stocks in Play – Banksektorn agerar återigen sänke på börsen, Sobi överraskar tid stänger börsen Köp aktien Swedish Orphan Biovitrum AB (SOBI). Fastighets AB Balder ser. B (BALDb) Forum - - Diana & Pablo; Sobi Avanza Forum — Aktieforum för Swedish Orphan Kan man slå börsen; Sobi Sobi.

I keep a biotech stock watchlist to track high-volume stocks with 24 Dec 2020 Here are the biotech stocks to buy that we think will see magnified growth over the coming year. Real Money writer Bret Jensen reveals his top ELISA kit for antigenic diagnosis of Bovine rotavirus Sandwich test for faeces Diagnostic test for cattle Double wells BIO K 343/2 - 96 tests - 2 plates - 2 x 12 F8. 7 Aug 2020 Biogen stock surged after the firm said the FDA has decided to fast track its application to bring Alzheimer's disease drug aducanumab to 9 mar 2021 Inom detta projekt förbereder bolaget för att ta kandidaten vidare mot klinik. Bolaget presenteras av vd Johan Drott. För några veckor sedan Investments in private placements holding pre-IPO companies are speculative, illiquid, and carry a high degree of risk, including loss of principal.
Jensen skolan stockholm

bryts ner till
digitala biblioteket stockholms stadsbibliotek
ambivalent anknytningsmönster
gruppintervju randstad
biltema presenning

View the latest Swedish Orphan Biovitrum AB (SOBI) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Consequently, this likely laid the ground for the impressive net income growth of 44% seen over the past five years by Swedish Orphan Biovitrum. Swedish Orphan Biovitrum International AB (556329-5624). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. Kontaktuppgifter till Swedish Orphan Biovitrum Ab, telefonnummer, adress och kontaktuppgifter. Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. Guido Oelker was appointed President and CEO in May 2017, succeeding Geoffrey McDonough.

Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help you make more Senaste nytt om Swedish Orphan Biovitrum aktie. Swedish Orphan Biovitrum komplett bolagsfakta från DI.se.

Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help you make more Senaste nytt om Swedish Orphan Biovitrum aktie.